The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030 Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science community For more information please click on the following link: https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html